Journals

Journals
Selection of journals extracted from ISI Web of Knowledge with Toxicology filtering, ranked by Impact Factor and grouped as Toxicology Journals, and list of Journals including Toxicology articles. Sorted by Impact Factor 2014, Journal Citation Report published by Thomson Reuters 2015.

Toxicology Journals

  • Annual Review of Pharmacology and Toxicology (IF2014: 18.365, IF2013: 18.523, IF2012: 21.543, IF2011: 21.64, IF2010: 19.24, IF2009: 22.47) is one of the 40 journals of Annual Reviews that offer comprehensive, timely collections of critical reviews written by leading scientists focused within the Biomedical, Physical, and Social Sciences disciplines.
  • Archives of Toxicology (IF2014: 5.980, IF2013: 5.078, IF2012: 5.215, IF2011: 4.674, IF2010: 4.041, IF2009: 3.312) provides up-to-date information on the latest advances in toxicology focus on: molecular mechanisms of toxic substances, in vitro techniques for toxicity testing and regulatory toxicology, advances in “omics” techniques for identification and classification of toxic substances, and mechanisms and relevance of metabolic activation and inactivation. The journal places particular emphasis on studies relating to defined effects of chemicals and mechanisms of toxicity, including toxic activities at the molecular level, in humans and experimental animals. Coverage includes new insights into analysis and toxicokinetics and into forensic toxicology. Review articles of general interest to toxicologists are an additional important feature of the journal.
  • Critical Reviews in Toxicology (IF2014: 5.097, IF2013: 6.414, IF2012: 6.253, IF2011: 5.160, IF2010: 3.960, IF2009: 4.232) provides up-to-date, objective analyses of topics related to the mechanisms of action, responses, and assessment of health risks due to toxicant exposure. The journal publishes critical, comprehensive reviews of research findings in toxicology and the application of toxicological information in assessing human health hazards and risks.
  • Toxicological Sciences (IF2014: 3.854, IF2013: 4.478, IF2012: 4.328, IF2011: 4.652, IF2010: 5.09, IF2009: 4.814) publishes premier peer-reviewed, hypothesis-driven, original research articles in all areas of toxicology.
  • Toxicology and Applied Pharmacology (IF2014: 3.705, IF2013: 3.630, IF2012: 3.975, IF2011: 4.447, IF2010: 3.993, IF2009: 3.359) publishes original scientific research pertaining to action of chemicals, drugs, or natural products to animals or humans. Articles address mechanistic approaches to physiological, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Papers concerned with alternatives to the use of experimental animals are encouraged.
  • Toxicology (IF2014: 3.621, IF2013: 3.745, IF2012: 4.017, IF2011: 3.681, IF2010: 3.641, IF2009: 3.241) advances the scientific understanding of mechanisms of toxicity. Emphasis will be placed on toxic effects observed at relevant exposures, which have direct impact on safety evaluation and risk assessment. All manuscripts published in Toxicology are subject to rigorous peer review. In addition to original research articles, concise and current review and mini-review articles are also welcome, as are personal opinion papers and commentaries.
  • Chemical Research in Toxicology (IF2014: 3.529, IF2013: 4.190, IF2012: 3.667, IF2011: 3.779, IF2010: 4.148, IF2009: 3.740) provides the latest findings on the molecular mechanisms by which toxic agents (chemical and biological) interact with living systems.
  • NeuroToxicology (IF2014: 3.379, IF2013: 3.054, IF2012: 2.652, IF2011: 3.096, IF2010: 2.921, IF2009: 2.918) specializes in publishing the best peer-reviewed original research papers dealing with the effects of toxic substances on the nervous system of humans and experimental animals of all ages. The journal emphasizes papers dealing with the neurotoxic effects of environmentally significant chemical hazards, manufactured drugs and naturally occurring compounds. Papers dealing with the effects of neurotoxicants on other systems (e.g. reproductive, endocrine, immune) or processes (e.g. metabolic) are also welcome.
  • Toxicology Letters (IF2014: 3.262, IF2013: 3.355, IF2012: 3.145, IF2011: 3.230, IF2010: 3.581, IF2009: 3.479) goes for the rapid publication of short reports on all aspects of toxicology, especially mechanisms of toxicity. The journal serves as a multidisciplinary forum for research in all areas of toxicology. The prime aim is rapid publication of research letters with sufficient importance, novelty and breadth of interest. In addition to research letters, papers presenting hypotheses and commentaries addressing current issues of immediate interest to other investigators are invited. Mini-reviews in various areas of toxicology will also be published. A new feature is the provision of a forum for the discussion and interpretation of data published in the journal. Clinical, occupational and safety evaluation, legal, risk and hazard assessment, impact on man and environment studies of sufficient novelty to warrant rapid publication is considered. The final pages of each issue provide information on forthcoming meetings, symposia and workshops.
  • Journal of Applied Toxicology (IF2014: 2.982, IF2013: 3.174, IF2012: 2.597, IF2011: 2.478, IF2010: 2.322, IF2009: 2.073) publishes reviews and research articles on mechanistic, fundamental and applied research relating to the toxicity of drugs and chemicals at the molecular, cellular, tissue, target organ and whole body level in vivo (by all routes of exposure) and in vitro / ex vivo. Focus is on toxicogenomics and proteomics, teratogenesis / developmental / reproductive toxicology, carcinogenesis, mutagenesis, pharmacokinetics, pharmacotoxicological and metabolic mechanisms, risk assessment, environmental toxicology and environmental health as applied to humans (including epidemiological studies). In addition the journal also publishes analytical and method development studies, mechanistic and molecular toxicology studies on novel or existing drugs and chemicals, addressing important or topical aspects of toxicology. Special emphasis is given to papers of clear relevance to human health and regulatory pharmaceutical / chemical toxicology.
  • Toxicology in Vitro (IF2014: 2.903, IF2013: 3.207, IF2012: 2.650, IF2011: 2.775, IF2010: 2.546, IF2009: 2.060) publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The journal focuses on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivofindings. The journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals).
  • Expert Opinion on Drug Metabolism and Toxicology (IF2014: 2.831, IF2013: 2.934, IF2012: 2.944, IF2011: 3.119, IF2010: 3.374, IF2009: 3.076) is a peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
  • Drug Safety (IF2014: 2.824, IF2013: 2.620, IF2012: 3.408, IF2011: 3.634, IF2010: 3.599, IF2009: 3.522) covers the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Specializing in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. Benefit-risk assessments provide an in-depth review of adverse effect and efficacy data for a drug in a defined therapeutic area. Also featured are reviews covering drug use in particular ‘at-risk’ patient groups, concept reviews on methodology, editorials and commentaries on topical issues and high quality original research focusing on the clinical implications of drug safety treatment issues.
  • Cell Biology and Toxicology (IF2014: 2.677, IF2013: 1.971, IF2012: 2.338, IF2011: 2.511, IF2010: 2.056, IF2009: 1.746) is an international journal which publishes papers of high scientific standards in the areas of cell biology, genetic, molecular and cellular toxicology. The journal presents scientific reports dealing with the basic biology and with the physiological, pharmacological, and toxic response of cellular systems. Studies of subcellular and cellular systems derived from both prokaryotic and eukaryotic cell types are also included. Studies of toxic effects may include, but are not limited to, cytotoxicity, mutagenicity, carcinogenicity, and teratogenicity. In particular, the journal emphasizes approaches to cellular studies or molecular structure activity correlations that provide sound scientific information leading to the decreased use of experimental animals.
  • Comparative Biochemistry and Physiology – Part C: Toxicology and Pharmacology (IF2014: 2.301, IF2013: 2.829, IF2012: 2.707, IF2011: 2.616, IF2010: 2.325, IF2009: 2.582) is concerned with chemical and drug action at different levels of organization, biotransformation of xenobiotics, mechanisms of toxicity, including reactive oxygen species and carcinogenesis, endocrine disruptors, natural products chemistry, and signal transduction with a molecular approach to these fields.
  • Mutation Research – Genetic Toxicology (IF2014: 2.415, IF2013: 2.481, IF2012: 2.220, IF2011: 3.065, IF2010: 2.938, IF2009: 2.552) publishes complete papers on the testing of chemicals for genetic toxicity, monitoring and/or surveillance of human populations for genotoxic effects, development, evaluation, and validation of new testing and monitoring methods, effects of environmental mutagens on species composition in ecosystems, and assessments of genetic risks resulting from induction of mutations in germ cells.
  • Basic and Clinical Pharmacology and Toxicology (IF2014: 2.377, IF2013: 2.294, IF2012: 2.124, IF2011: 2.179, IF2010: 2.371, IF2009: 2.308) publishes original scientific research in all fields of experimental pharmacology and toxicology, including biochemical, cellular and molecular pharmacology and toxicology. Manuscripts on clinical pharmacology and its aspects, pharmacodynamics and pharmacokinetics are also accepted.
  • Toxicologic Pathology (IF2014: 2.137, IF2013: 2.063, IF2012: 2.063, IF2011: 1.913, IF2010: 2.168, IF2009: 2.508) focuses on the multidisciplinary elements that constitute toxicologic pathology, including spontaneous and experimentally induced morphological and functional changes, environmental exposures, case reports, and risk assessment and investigative techniques.
  • Regulatory Toxicology and Pharmacology (IF2014: 2.031, IF2013: 2.142, IF2012: 2.132, IF2011: 2.427, IF2010: 2.162, IF2009: 1.798) reports the concepts and problems involved with the generation, evaluation, and interpretation of experimental animal and human data in the larger perspective of the societal considerations of protecting human health and the environment. The journal is devoted to reports of significant developments, public opinion, scientific data, and ideas that bridge the gap between scientific information and the legal aspects of toxicological and pharmacological regulations.
  • Cardiovascular Toxicology (IF2014: 1.721, IF2013: 2.060, IF2012: 2.351, IF2011: 2.067, IF2010: 1.809, IF2009: 2.561) is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. The journal publishes papers that elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.

Journals including Toxicology articles

  • New England Journal of Medicine (IF2014: 55.873, IF2013: 54.42, IF2012: 51.658, IF2011: 53.298, IF2010: 53.484, IF2009: 47.050) offers the latest medical research, Significant clinical trials, Ground-breaking case studies, Expert review articles, Lively editorials & commentary and Revealing clinical images.
  • Nature Reviews Drug Discovery (IF2014: 41.908, IF2013: 37.231, IF2012: 33.078, IF2011: 29.008, IF2010: 28.712, IF2009: 29.059) is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.
  • Nature (IF2014: 41.456, IF2013: 42.351, IF2012: 38.597, IF2011: 36.280, IF2010: 36.101, IF2009: 34.480) is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.
  • Nature Chemical Biology (IF2014: 12.996, IF2013: 13.217, IF2012: 12.948, IF2011: 14.690, IF2010: 15.808, IF2009: 16.058) provides basic information, current highlights, and reference tools for a variety of current topics in chemical biology.
  • Annual Review of Medicine (IF2014: 12.928, IF2013: 15.478, IF2012: 14.603, IF2011: 13.104, IF2010: 12.457, IF2009: 9.940) is one of the 40 journals of Annual Reviews that offer comprehensive, timely collections of critical reviews written by leading scientists focused within the Biomedical, Physical, and Social Sciences disciplines.
  • Trends in Biotechnology (IF2014: 11.958, IF2013: 10.040, IF2012: 9.960, IF2011: 9.148, IF2010: 9.644, IF2009: 6.909) is unique in drawing together a wide readership of scientists and engineers from the many disciplines of the applied biosciences. As in the successful biotechnology companies and leading academic research groups, This journal reflects the view that biotechnology is the integrated use of many biological technologies – from molecular genetics to biochemical engineering. This integration is essential for the effective translation of novel research into application. The journal addresses what is new, significant and practicable.
  • Trends in Pharmacological Sciences (IF2014: 11.539, IF2013: 9.988, IF2012: 9.250, IF2011: 10.927, IF2010: 11.050, IF2009: 9.064) is one of the leading monthly review journals in pharmacology and toxicology. Every issue of Trends in Pharmacological Sciences contains succinct articles on the most exciting recent developments in pharmacology and toxicology research: topics covered in the journal range from molecular to behavioural pharmacology, and from current techniques to theoretical pharmacology. Trends in Pharmacological Sciences has a prestigious Advisory Editorial Board that attest to the journal’s established reputation as essential reading for all pharmacologists and toxicologists, from students to professors and directors.
  • Molecular Aspects of Medicine (IF2014: 10.238, IF2013: 10.302, IF2012: 10.375, IF2011: 9.970, IF2010: 10.552, IF2009: 6.492) has as the primary objective of this publication to encourage the bridging of the gap between clinicians of all relevant specialities and biomedical scientists working in areas from biochemistry and molecular and cell biology to physiology, pharmacology and pathology. A spectrum of topics in medicine will be selected to illustrate not only the molecular insights that derive from the application of basic science, but also the variety of challenging problems that medicine is able to offer the basic scientist. The Editors and publisher anticipate that most of the authors contributing to the series will be practising clinical scientists who will develop their own personal perspective as an extended review on the molecular aspects of a field of medicine in which they are working, addressing themselves both to the doctor who is ill-at-ease with basic science, and to the basic scientist with little awareness of the problems of clinical practice.
  • Pharmacology and Therapeutics (IF2014: 9.723, IF2013: 7.745, IF2012: 7.793, IF2011: 8.562, IF2010: 8.694, IF2009: 8.897) presents lucid, critical and authoritative reviews of currently important topics in pharmacology.
  • Nucleic Acids Research (IF2014: 9.112, IF2013: 8.808, IF2012: 8.278, IF2011: 8.026, IF2010: 7.836, IF2009: 7.479) publishes the results of leading edge research into physical, chemical, biochemical and biological aspects of nucleic acids and proteins involved in nucleic acid metabolism and/or interactions. It enables the rapid publication of papers under the following categories: Chemistry and synthetic biology; Computational biology; Gene regulation, chromatin and epigenetics; Genome integrity, repair and replication; Genomics; Molecular biology; Nucleic acid enzymes; RNA and Structural biology. A Survey and Summary section provides a format for brief reviews. The first issue of each year is devoted to biological databases, and an issue in July is devoted to papers describing web-based software resources of value to the biological community.
  • Clinical Pharmacology and Therapeutics (IF2014: 7.903, IF2013: 7.390, IF2012: 6.846, IF2011: 6.043, IF2010: 6.978, IF2009: 6.961) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original articles, letters and communications in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.
  • Drug Discovery Today (IF2014: 6.691, IF2013: 5.964, IF2012: 6.551, IF2011: 6.828, IF2010: 6.422, IF2009: 6.630) delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
  • British Journal of Pharmacology (IF2014: 4.842, IF2013: 4.99, IF2012: 5.067, IF2011: 4.409, IF2010: 4.925, IF2009: 5.204) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. Its scope includes: Anti-infective drugs,Biopharmaceuticals,Cancer pharmacology,Cardiovascular pharmacology, Drug discovery, Drug safety & toxicology, Endocrine & metabolic pharmacology, Gastrointestinal pharmacology, Genitourinary & renal pharmacology, Immunopharmacology & Inflammation, Molecular & cellular mechanisms, Neuropharmacology, Pharmacokinetics & drug metabolism, Respiratory system pharmacology, Methods & techniques, Social impact of pharmacology.
  • Journal of Cheminformatics (IF2014: 4.547, IF2013: 4.54, IF2012: 3.59, IF2011: 3.419) is an open access journal publishing original peer-reviewed research in all aspects of cheminformatics and molecular modelling. Coverage includes, but is not limited to: 1) chemical information systems, software and databases, and molecular modelling, 2) chemical structure representations and their use in structure, substructure, and similarity searching of chemical substance and chemical reaction databases, and 3) computer and molecular graphics, computer-aided molecular design, expert systems, QSAR, and data mining techniques.
  • Pharmacological Research (IF2014: 4.408, IF2013: 3.976, IF2012: 4.346, IF2011: 4.436, IF2010: 3.612, IF2009: 3.929) provides a rapid information exchange medium for specialists within the discipline of pharmacology. The journal publishes papers on basic and applied pharmacological research and is proud of its rapid publication of accepted papers.
  • Molecular Pharmaceutics (IF2014: 4.384, IF2013: 4.787, IF2012: 4.570, IF2011: 4.416, IF2010: 5.400, IF2009: 5.408) publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science ad they relate to drug and drug delivery system efficacy.
  • Drugs (IF2014: 4.343, IF2013: 4.133, IF2012: 4.633, IF2011: 4.226, IF2010: 3.738, IF2009: 4.732) provides detailed and genuinely objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
  • Journal of Chemical Information and Modeling (IF2014: 3.738, IF2013: 4.068, IF2012: 4.304, IF2011: 4.675, IF2010: 3.822, IF2009: 3.882) publishes papers reporting new methodology and/or important applications in the fields of chemical informatics and molecular modeling. Specific topics include the representation and computer-based searching of chemical databases, molecular modeling, computer-aided molecular design of new materials, catalysts, or ligands, development of new computational methods or efficient algorithms for chemical software, and biopharmaceutical chemistry including analyses of biological activity and other issues related to drug discovery.
  • Mutation Research – Fundamental and Molecular Mechanisms of Mutagenesis (IF2014: 3.680, IF2013: 4.440, IF2012: 3.902, IF2011: 2.850, IF2010: 3.204, IF2009: 3.556) broadly encompasses all aspects of research that address the detection of mutations, the mechanisms by which mutations in genes and chromosomes arise, and the modulation of mutagenesis by mutation avoidance pathways such as DNA repair, cell cycle control and apoptosis. It includes the role of genetic variation in the genesis and manifestation of mutations, ranging from the variable manner in which xenobiotics are metabolized to variations in the capacity of cells to replicate and repair damaged DNA. It also includes the contributions of these mechanisms, when perturbed, to animal disease models and to human disease, with particular emphasis on carcinogenic mechanisms.
  • Journal of Computer-Aided Molecular Design (IF2014: 2.990, IF2013: 2.782, IF2012: 3.172, IF2011: 3.386, IF2010: 3.374, IF2009: 3.835) provides a form for disseminating information on both the theory and the application of computer-based methods in the analysis and design of molecules.
  • ChemMedChem (IF2014: 2.968, IF2013: 3.046, IF2012: 2.835, IF2011: 3.151, IF2010: 3.306, IF2009: 3.232) is on its way to become a premier journal at the interface of chemistry, biology and medicine. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies—to name just a few topics.
  • Food and Chemical Toxicology (IF2014: 2.895, IF2013: 2.610, IF2012: 3.010, IF2011: 2.999, IF2010: 2.602) publishes original research articles, reviews, and case reports on the toxic effects,in animals or humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food safety, chemical safety, and other areas of consumer product safety. Research papers with a clear scientific contribution to the field of food/chemical toxicology will be given preference in the review process. Manuscripts concerning materials/substances of only local interest for which the chemical composition of the material/substance is not clearly defined will not be considered. In addition to these areas, papers on industrial and agricultural chemicals and pharmaceuticals are encouraged. Furthermore new areas such as safety evaluation of novel foods and ingredients and biotechnologically derived products, including nanomaterials and inter-relationships between nutrition and toxicology are encouraged. Studies should address the physiological, biochemical or pathological changes induced by specific substances, techniques for assessing potential toxicity, including molecular biology or the mode/mechanisms underlying toxic phenomena. All aspects of in vivo toxicology are covered, including systemic effects on specific organ systems, immune functions, carcinogenesis and reproductive/developmental toxicology. Papers reporting the toxicological examination of specific chemicals or consumer products are published irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards of scientific adequacy. FCT encourages submission of in vitro papers, particularly those fostering the 3 Rs.
  • Neurotoxicology and Teratology (IF2014: 2.762, IF2013: 3.224, IF2012: 3.181, IF2011: 2.983, IF2010: 2.622, IF2009: 3.274) presents original reports of systemic studies in the areas of adult neurotoxicology and developmental neurotoxicology in which the primary emphasis and theoretical context are on the nervous system and/or behavior. The Journal publishes original, peer–reviewed studies that cover the developmental and adult neurotoxicity of pesticides, drugs of abuse, pharmaceuticals, solvents, heavy metals, organometals, general industrial-use compounds, marine and plant toxins, atmospheric reaction compounds, and physical agents such as radiation and noise. Neurotoxicology and Teratology also features Brief Communications that concisely describe a new method, technique, or apparatus and experimental results. Invited Reviews and Open Peer Commentary series provide a timely update on selected aspects of a scientific field undergoing rapid change or on areas that present special methodological or interpretive problems.
  • Chemico-Biological Interactions (IF2014: 2.577, IF2013: 2.982, IF2012: 2.967, IF2011: 2.865, IF2010: 2.832, IF2009: 2.457) publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.
  • Bioorganic and Medicinal Chemistry Letters (IF2014: 2.420, IF2013: 2.331, IF2012: 2.338, IF2011: 2.554, IF2010: 2.661, IF2009: 2.650) presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.
  • Molecular Informatics (IF2014: 1.647, IF2013: 2.013, IF2012: 2.338, IF2011: 2.39, IF2010: 0.593) presents methodological innovations that will lead to a deeper understanding of ligand-receptor interactions, macromolecular complexes, molecular networks, design concepts and processes that demonstrate how ideas and design concepts lead to molecules with a desired structure or function, preferably including experimental validation. The journal’s scope includes but is not limited to the fields of drug discovery and chemical biology, protein and nucleic acid engineering and design, the design of nanomolecular structures, strategies for modeling of macromolecular assemblies, molecular networks and systems, pharmaco- and chemogenomics, computer-assisted screening strategies, as well as novel technologies for the de novo design of biologically active molecules. As a unique feature Molecular Informatics publishes so-called “Methods Corner” review-type articles which feature important technological concepts and advances within the scope of the journal.
  • SAR and QSAR in Environmental Research (IF2014: 1.596, IF2013: 1.924, IF2012: 1.667, IF2011: 2.086, IF2010: 1.560, IF2009: 1.682) is an international journal welcoming papers on the fundamental and practical aspects of the structure-activity and structure-property relationships in the fields of environmental science, agrochemistry, toxicology, pharmacology and applied chemistry. A unique aspect of the journal is the focus on emerging techniques for the building of SAR and QSAR models in these widely varying fields. The scope of the journal includes, but is not limited to, the topics of topological and physicochemical descriptors, mathematical, statistical and graphical methods for data analysis, computer methods and programs, original applications and comparative studies. In addition to primary scientific papers, the journal contains reviews of books and software and news of conferences. Special issues on topics of current and widespread interest to the SAR and QSAR community will be published from time to time.
  • Toxicology Mechanisms and Methods (IF2014: 1.517, IF2013: 1.548, IF2012: 1.367, IF2011: 1.033, IF2010: 0.844, IF2009: 0.752) is a peer-reviewed journal whose aim is twofold. Firstly, the journal contains original research on subjects dealing with the mechanisms by which foreign chemicals cause toxic tissue injury. Chemical substances of interest include industrial compounds, environmental pollutants, hazardous wastes, drugs, pesticides, and chemical warfare agents. The scope of the journal spans from molecular and cellular mechanisms of action to the consideration of mechanistic evidence in establishing regulatory policy.
  • Current Opinion in Drug Discovery and Development (No longer Published in 2011, IF2011: 4.202, IF2010: 4.507, IF2009: 4.904) is a bimonthly review journal that has established itself as a unique journal encompassing all chemical aspects of drug R&D, from the initial concept stage, through to process development.